SCHEMBL14950441

SCHEMBL14950441

Cc1cc(C)c(OCCN2CCNC2=O)c(C)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
SCN9A Q15858 3/20 0.40
POLB P06746 3/20 0.40
PDK2 Q15119 1/20 0.39
SCN5A Q14524 2/20 0.39
SCN2A Q99250 1/20 0.38
SCN3A Q9NY46 1/20 0.38
SCN8A Q9UQD0 1/20 0.38
RAB9A P51151 1/20 0.38
P2RY12 Q9H244 1/20 0.37
BRD4 O60885 1/20 0.37
ALK Q9UM73 1/20 0.35
HTR2A P28223 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18909902 0.86 PDK2 (0.39) KMT2AMEN1SMN1; SMN2SCN9APOLB
SCHEMBL361472 0.86 SCN9A (0.37) KMT2AMEN1SMN1; SMN2SCN9APOLB
SCHEMBL30229597 0.85 ALK (0.40) KMT2AMEN1SMN1; SMN2SCN9APOLB
SCHEMBL18344266 0.85 ALK (0.40) KMT2AMEN1SMN1; SMN2SCN9APOLB
SCHEMBL18533588 0.84 SCN9A (0.36) KMT2AMEN1SMN1; SMN2SCN9APOLB
SCHEMBL17612725 0.84 SCN9A (0.36) KMT2AMEN1SMN1; SMN2SCN9APOLB
SCHEMBL365754 0.82 HPGD (0.39) KMT2AMEN1SMN1; SMN2SCN9APOLB
SCHEMBL18533590 0.82 PDK2 (0.36) KMT2AMEN1SMN1; SMN2SCN9APOLB
SCHEMBL17612729 0.82 PDK2 (0.36) KMT2AMEN1SMN1; SMN2SCN9APOLB
SCHEMBL10033207 0.82 BRD4 (0.36) KMT2AMEN1SMN1; SMN2SCN9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593485-B1 POLYMERS CRAFTET WITH AZOTIC MOLECULES MICHELIN & CIE (FR) 2016-03-23 EP disclosed
US-20130197237-A1 MOLECULES HAVING COMBINABLE GROUPS ARKEMA FRANCE (FR) 2013-08-01 US disclosed
US-20130131279-A1 GRAFT POLYMER TO WHICH COMBINED NITROGEN MOLECULES ARE GRAFTED Mchelin Recherche et Technique S.A. (CH) 2013-05-23 US disclosed
US-20130123418-A1 RUBBER COMPOSITION CONTAINING A MODIFED ELASTOMER, METHOD FOR PREPARING SAME, AND TIRE CONTAINING SAME MICHELIN RECHERCHE ET TECHNIQUE S.A. (CH) 2013-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130197237-A1 MOLECULES HAVING COMBINABLE GROUPS NCAPH, NCL, PARG KMT2A 3304/4885MEN1 1074/4885SMN1; SMN2 4018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.